Donald I. Abrams, MD
Donald AbramsDr. Abrams is chief of Hematology-Oncology at San Francisco General Hospital and a Professor of Clinical Medicine at the University of California San Francisco. After completing a fellowship in Integrative Medicine with the University of Arizona, he began an Integrative Oncology consultative practice and the UCSF Osher Center for Integrative Medicine. He focuses his consultation on nutrition, physical activity and the use of dietary supplements. His particular areas of research interest are in the use of medicinal mushrooms, cannabis and traditional Chinese medicine interventions in people living with and beyond cancer. He is the co-editor with Andrew Weil of the Oxford University Press text Integrative Oncology. He serves on the editorial board of the National Cancer Institute’s PDQ CAM website.

M. Alejandro Chaoul, PhD
Dr. Chaoul specializes in mind-body applications, conducting research using these techniques with cancer patients. He holds group and individual meditation classes and clinic for cancer patients and their support system at M.D. Anderson’s Integrative Medicine Center. He is also an associate faculty member at The University of Texas’ McGovern Center for Humanities and Ethics, where he teaches medical students in the areas of spirituality, complementary and integrative medicine, and end of life care.

For over ten years he has been actively involved in research overseeing the mind-body components of NCI-funded and non-funded randomized controlled trials examining different cancer populations. His academic and contemplative background in Tibetan mind-body practices have been instrumental in designing various mind-body interventions, including the Tibetan Sound Meditation for women with breast cancer that express cognitive impairment, which will be the focus of this workshop.

Dr. Chaoul holds a PhD in Indo-Tibetan Buddhism from Rice University and also completed a seven-year meditation training program at Ligmincha Institute in 1999. Since 1995, he has been teaching meditation classes and workshops nationally and internationally. In 1999 he began teaching these techniques at M.D. Anderson’s Integrative Medicine Center, and also for the Faculty Health and Wellbeing program.

Moses S.S. Chow, Pharm.D.

Dr. Chow has been involved in pharmacy education, research and clinical practice for 40 years. He was a faculty member at the University of Connecticut School of Pharmacy, Storrs, Connecticut and Director of the School of Pharmacy, Faculty of Medicine, the Chinese University of Hong Kong. Currently, he is Professor and Director of the Center for Advancement of Drug Research and Evaluation (CADRE), College of Pharmacy at the Western University of Health Sciences, Pomona, USA.

His research activities include clinical pharmacology, pharmacokinetics (pharmacogenetics) and Chinese herbal medicine. His current research interest focuses on drug development, especially on Chinese herbal medicine for cancer.

Dr. Chow has authored/co-authored 10 books, over 600 publications (journal articles, abstracts). Furthermore, he has given over two hundred lectures locally, regionally, nationally and internationally to health professionals, academic institutions and scientists and has participated and organized numerous symposiums and workshops at various professional society meetings, eg. American Health-system Pharmacists Midyear Clinical Meeting, American College of Clinical Pharmacology Annual Meeting, and Asian Association of Schools of Pharmacy Conferences. Dr. Chow also has been Editor or an editorial advisory board member of a number of Scientific and health care professional journals.

Moshe Frenkel, MD

Dr. Frenkel is a clinical associate professor at the University of Texas and founder of the Integrative Medicine Clinic, at The University of Texas M. D. Anderson Cancer Center, Houston Texas.Dr. Frenkel is Board certified in Family Practice, earned his medical degree from Sackler School of Medicine, Tel Aviv University, Israel and completed his family practice residency in New York.  Prior to joining M.D. Anderson Cancer Center  he was serving as a faculty in University of Texas Medical Branch at Galveston and served as a key contributor to an NIH grant on integrating Complementary and Integrative Medicine (CIM) into the medical school curriculum, as well as providing CIM consultations to patients and families.   Since 2011 Dr Frenkel is leading an integrative oncology service in the Oncology Institute in Meir Medical Center in Israel. as well as, chairing the clinical practice committee of The Society of Integrative Oncology.

Eva Grunfeld, MSc, MD, DPhil, FCFP
Eva GrunfeldProfessor and Vice Chair, Research, Department of Family and Community Medicine, University of Toronto
Clinician Scientist, Ontario Institute for Cancer Research

Dr. Eva Grunfeld is a physician scientist with the Ontario Institute for Cancer Research, Health Services Research Program and Director of the Knowledge Translation Research Network. At the same time she is the Giblon Professor and Vice Chair, Research, in the Department of Family and Community Medicine, University of Toronto. She obtained her medical degree from McMaster University and doctoral degree in cancer epidemiology from Oxford University.

Dr. Grunfeld is a leader in cancer health services and outcomes research. Her research focuses on evaluation and knowledge translation of cancer health services, covering the entire spectrum of cancer control activities. She uses a mixed-methods approach including randomized controlled trials, qualitative research and outcomes research. Dr. Grunfeld holds many peer-review grants as Principal Investigator and has served on many committees to further the goals of cancer control in Canada and internationally.

Dr. Michelle Kohn, FRCP

MKohnDr Kohn is a Specialist in Supportive Cancer Care and Director of the Living Well Programme at Leaders in Oncology Care (LOC), a leading cancer treatment centre in London, where patients are offered this Programme as part of their treatment and care.

In November 2009, Dr Kohn joined LOC to create and direct a programme of cancer survivorship. This was launched as the Living Well Programme in early 2010, in consultation with patients and the LOC team. The Programme aims to meet patients' total care needs during and after treatment by means of a clinical service supported by materials, education for health professionals, underpinned by research to guide service development. This successful Programme continues to be led and facilitated by Dr Kohn, with a growing team of professional collaborators and the support of LOC's eminent oncologists and support team, who are developing Living Well into an integral and highly valued part of patient care.

Dr Kohn qualified in medicine at University College and Middlesex School of Medicine, London (1990), with a distinction in pharmacology and therapeutics. After completing further medical training she went on to work in the development of clinical trials.

She resumed her interest in oncology in 1996 whilst working at Mount Vernon Cancer Centre and was then appointed Medical Advisor to Macmillan Cancer Support (1998-2005) to develop their integrative oncology programme and supportive care services. She was subsequently appointed Advisor to Breakthrough Breast Cancer (2006-2007) to guide their research programme in integrative oncology.

She has produced various reports which have been published nationally and internationally and she has lectured widely on integrative and supportive cancer care in the UK and USA, including for the NCRI, UK and for NCI, USA as well as for various public and voluntary sector organisations and cancer centres in the UK and abroad.

Dr Kohn is a former Board member of the Society for Integrative Oncology and was elected to Fellowship of the Royal College of Physicians, London, in 2012 for her work in cancer survivorship and supportive cancer care.

Irene Martyniuk, LAC
Irene Martyniuk is a 2001 graduate of the New England School of Acupuncture and was the first non-physician credentialed as an acupuncturist at Massachusetts General Hospital.  She has worked at the MGH Cancer Center since 2004 and is part of a team which planned and implemented acupuncture program expansion into 6 new clinical areas and increased hours of acupuncture service from 3 hours per week to over 100.  She now leads a five member acupuncture team which works in both inpatient and outpatient settings and with both pediatric and adult patients.

She also provides in-service education to patients, clinical staff and support staff and twice monthly patient education sessions.  She has organized interactive workshops for patients which focused on learning and using self care strategies.  She has taught staff workshops which focused on how to talk with patients about integrative therapies.

Carole O’Toole, MS

Carole O’Toole is Director of Integrative Navigation for Smith Center for Healing and the Arts in Washington DC, a nonprofit health, education and creative arts organization that serves individuals, families and health professionals dealing with cancer. 

She has designed and directed both hospital and community-based patient navigation programs that have reached over 12,000 of the city’s underserved residents. She is also co-creator and co-facilitator with Laura Pole of a national training program in integrative cancer care navigation for health care professionals and lay navigators. She has led workshops and trainings in integrative navigation since 2009.

Ms. O’Toole, who holds a masters degree in medical anthropology and health policy, co-founded ”Finding My Way”, a cancer coaching practice, where she focused on integrative care and the spiritual path of survivorship.

Ms. O’Toole is the author of two books on integrative cancer care: “Healing Outside the Margins” (Lifeline Press), and “Cancer Community Healing Network” (Silver Lining Press), has consulted with area hospitals on integrative cancer care, and has been a Patient Navigator at a Washington DC area hospital breast center. She lives with her family in Kensington Maryland and is celebrating her 19th year of cancer survivorship.

Glenn Sabin

Glenn SabinGlenn Sabin is a veteran marketing and business development executive who for over two decades led an award-winning media and content marketing firm in the Washington, D.C. metropolitan area. 

Recognizing the need for business development strategy and support specific to the delivery of integrative healthcare services, coupled with his interest in whole systems, non-reductionistic integrative oncology research models, Glenn founded FON Therapeutics, Inc. in 2006.



Kenneth J. Sapire, MD
Dr.  Sapire grew up and was educated in Africa which molded his interests in life.  After medical school in Cape Town, he has been living in America following postgraduate training completed in Anesthesia and Pediatric residencies in New York. As an anesthesiologist, he works in a complex medical environment, MD Anderson Cancer Center, and has developed a strong interest in integrative medicine.  He educates medical students and teaches the "Healers Art" course, and conducting national and international presentations has been a major focus of academic interest. He teaches on issues of mindfulness, stress, burnout and the relief thereof through local and national programs. This is a richly rewarding collaboration involving the medical community, in and out of the United States. He successfully applied this training and insight acquired directly in patient care thus discovering a fascinating positive development in my own clinical practice. We are in a phase of constant change with many areas of turmoil in our daily lives; his attention has been drawn to finding ways to better care for people with compassion as they move through their life as whole human beings.  He and Dr. Moshe Frenkel have collaborated on numerous integrative medicine projects in cancer medicine.

Debu Tripathy, MD

Debu TripathyDr. Tripathy is a medical oncologist with a research focus in the area of breast cancer that includes novel biologically targeted therapeutics and diagnostics and personalized decision-making. He is part of a multi-disciplinary breast cancer academic clinical practice and serves as Clinical Leader of the USC/Norris Comprehensive Cancer Center. He has designed and conducted integrative therapy studies including botanical agents, systems-based therapy for different indications in breast cancer treatment and supportive care. His area of funded research and track record of publications includes the testing of signal transduction inhibitors, identification of prognostic and predictive factors, and the laboratory-based and clinical testing of botanical agents for breast cancer. He is past President of the Society for Integrative Oncology, American Society of Breast Diseases and current Editor-in-Chief of CURE Magazine.

Marja J. Verhoef, PhD

Marja VerhoefMarja J.Verhoef, PhD is a Professor in the Department of Community Health Sciences at the University of Calgary and an Adjunct Professor at the National Research Centre in Complementary and Alternative Medicine, Faculty of Medicine, University of Tromsø, Norway.  She received a PhD in epidemiology from the University of Calgary and held a Canada Research Chair in Complementary Medicine for two terms (2001 – 2011). Her research focuses on a wide range of factors related to complementary and alternative medicine, including determinants of use, decision making, communication, information needs, meaning and importance of evidence and integration of CAM in conventional medicine. She is very interested in methodological issues such as identifying and developing appropriate designs to evaluate whole systems of treatment and care, as well as appropriate outcome measures to evaluate such systems. She is Co-Chair of the Canadian Interdisciplinary Network for CAM Research, leads the development of a large outcome measures database and was the first President of the International Society of Complementary Medicine Research.

Laura Weeks, PhD

Dr. Weeks is a Senior Research Fellow at the Ottawa Integrative Cancer Centre, where her research focuses on developing and evaluating integrative models of care and assessing the safety and effectiveness of complementary therapies and the integrative approach to care. She was the first student member of the Cancer and Complementary and Alternative Medicine Research Team, is the coordinator for the Integrative Canadian Oncology (ICON) Research Initiative, a member of the Society for Integrative Oncology, and plays an active role in the Canadian Interdisciplinary Network for Complementary and Alternative Medicine Research. Dr. Weeks regularly presents her research at national and international conferences, and is an experienced workshop facilitator.